Overall, our findings provide novel evidence for the central role of Ets2 in IL-6 trans-signaling induced cellular reprograming of RASFs to osteoclast-like cells and its contribution to RASF heterogeneity and bone destruction in RA. Here, ETS2 is linked to rheumatoid arthritis.